05Dec/13

Hypothalamic-Pituitary-Adrenal Axis Recovery Following Prolonged … – Journal of Clinical Endocrinology and Metabolism

Hypothalamic-Pituitary-Adrenal Axis Recovery Following Prolonged
Journal of Clinical Endocrinology and Metabolism
Design, Setting, and Participants: Before the adoption of propranolol treatment by the Vascular Birthmarks Clinic, 12 infants with infantile hemangioma received high-dose prednisolone for 12 to 25 weeks’ duration, weaned over 4 to 6 weeks, and ceased

25Nov/13

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS … – RTT News

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS
RTT News
Boston Scientific Corp. (BSX: Quote) said Monday that it has received U.S. Food and Drug Administration or FDA approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation durable 
Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus Wall Street Journal
Boston Scientific Receives FDA Approval For Promus Premier Everolimus Benzinga
FDA approves next-generation EESHealio
Forbes –MedCity News –Worcester Business Journal
all 10 news articles »
25Nov/13

Boston Scientific Corporation : Boston Scientific Receives FDA Approval For … – 4-traders (press release)

Boston Scientific Corporation : Boston Scientific Receives FDA Approval For
4-traders (press release)
25, 2013/PRNewswire/ — Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Promus PREMIER™ Everolimus-Eluting 

25Nov/13

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS … – NASDAQ

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS
NASDAQ
(RTTNews.com) – Boston Scientific Corp. ( BSX ) said Monday that it has received U.S. Food and Drug Administration or FDA approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation 
Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus Wall Street Journal
FDA approves next-generation EESHealio
BSX scores FDA device approval for drug-eluting stent for coronary artery MedCity News
Worcester Business Journal
all 10 news articles »